Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia

Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia

Leslie Citrome,1 Christoph U Correll,2– 6 Andrew J Cutler,7,8 Martin Dunbar,9 Amber R Hoberg,10 Craig Hopkinson,9 Gregory W Mattingly,11,12 James A McGrory,9 Bhaskar Rege,9 Peter J Weiden,13 David McDonnell14 1New York Medical College, Valhalla, NY, USA; 2Department of Psychiatry, The Zucker Hillsid...

Full description

Saved in:
Bibliographic Details
Main Authors: Citrome L, Correll CU, Cutler AJ, Dunbar M, Hoberg AR, Hopkinson C, Mattingly GW, McGrory JA, Rege B, Weiden PJ, McDonnell D
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
dosing
pharmacokinetics
phase 3 clinical trials
safety
treatment efficacy
treatment initiation
Online Access:https://www.dovepress.com/aripiprazole-lauroxil-development-and-evidence-based-review-of-a-long--peer-reviewed-fulltext-article-NDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/aripiprazole-lauroxil-development-and-evidence-based-review-of-a-long--peer-reviewed-fulltext-article-NDT

Similar Items